Portfolio (Quarterly)
Guide ↗
Avidity Partners Management LP
· CIK 0001791827| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 2,104,184.0 | $176.6M | 35.76% | NEW | — | $83.92 | -2.2% |
| 2 | CGON | CG ONCOLOGY INC | Healthcare | 1,288,948.0 | $87.2M | 17.67% | NEW | — | $67.68 | -12.0% |
| 3 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 760,424.0 | $37.3M | 7.55% | NEW | — | $49.05 | +42.5% |
| 4 | CATX | PERSPECTIVE THERAPEUTICS INC | Healthcare | 6,049,999.0 | $25.2M | 5.11% | NEW | — | $4.17 | -29.3% |
| 5 | JBIO | JADE BIOSCIENCES INC | Healthcare | 1,400,708.0 | $19.7M | 3.98% | NEW | — | $14.05 | +9.2% |
| 6 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 400,000.0 | $15.7M | 3.17% | NEW | — | $39.20 | +17.7% |
| 7 | TEVA | TEVA PHARM ADR | Healthcare | 450,100.0 | $13.6M | 2.75% | NEW | — | $30.12 | +15.0% |
| 8 | CNTX | CONTEXT THERAPEUTICS INC | Healthcare | 4,998,267.0 | $13.1M | 2.65% | NEW | — | $2.62 | -46.9% |
| 9 | RGEN | REPLIGEN CORP | Healthcare | 77,800.0 | $9.2M | 1.86% | NEW | — | $117.82 | +10.8% |
| 10 | PVLA | PALVELLA THERAPEUTICS INC | Healthcare | 70,000.0 | $8.7M | 1.77% | NEW | — | $124.65 | -12.7% |
| 11 | MDT | MEDTRONIC INC | Healthcare | 100,000.0 | $8.7M | 1.75% | NEW | — | $86.65 | -7.4% |
| 12 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 950,000.0 | $8.5M | 1.72% | NEW | — | $8.96 | -4.9% |
| 13 | AKTS | AKTIS ONCOLOGY INC | Healthcare | 468,566.0 | $8.4M | 1.70% | NEW | — | $17.89 | +22.6% |
| 14 | — | IMMUNIC INC | — | 6,699,411.0 | $7.4M | 1.51% | NEW | — | $1.11 | — |
| 15 | DXCM | DEXCOM | Healthcare | 90,000.0 | $5.7M | 1.15% | NEW | — | $62.80 | +20.0% |
| 16 | EHC | ENCOMPASS HEALTH CORP | Healthcare | 42,000.0 | $4.1M | 0.82% | NEW | — | $96.73 | +4.9% |
| 17 | BSX | BOSTON SCIENTIFIC CORPORATION | Healthcare | 60,000.0 | $3.8M | 0.76% | NEW | — | $62.75 | -25.2% |
| 18 | — | TENAX THERAPEUTICS INC | — | 215,934.0 | $3.5M | 0.70% | NEW | — | $15.99 | — |
| 19 | GILD | GILEAD SCIENCES INC | Healthcare | 20,000.0 | $2.8M | 0.56% | NEW | — | $139.37 | -9.9% |
| 20 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 249,390.0 | $2.8M | 0.56% | NEW | — | $11.11 | -6.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.5%
Consumer Defensive
0.4%
Consumer Cyclical
0.2%